Skills and experience: Prior to his current role, Jin was CFO for Alexion. Jin joined Alexion in 2017 and was responsible for driving strategic growth, financial performance and business development at Alexion. He brings operational experience in biopharma plus more than 20 years of professional experience at global financial institutions and has extensive knowledge of global healthcare systems, having closed more than 100 transactions across M&A, equity and debt financing.
Before joining Alexion, Jin was Managing Director of Healthcare Corporate and Investment Banking at Citi Global Banking, focusing on clients in the life sciences and biopharmaceutical sectors.
Previously, he served as Managing Director of Healthcare Investment Banking at UBS, and worked at JP Morgan in the M&A Advisory and Healthcare groups. He completed his accounting training at the University of Beijing and received his MBA from Stanford Business School.